For the year ending 2025-12-31, COYA made $7,945,753 in revenue. -$21,226,107 in net income. Net profit margin of -267.14%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration revenue | 7,945,753 | |||
| Research and development | 16,734,549 | |||
| In-process research and development | 2,289,602 | |||
| General and administrative | 11,449,466 | |||
| Depreciation | 27,361 | |||
| Total operating expenses | 30,500,978 | |||
| Loss from operations | -22,555,225 | |||
| Other income | 1,332,207 | |||
| Pre-tax loss | -21,223,018 | |||
| Income tax (expense) benefit | 3,089 | |||
| Net loss | -21,226,107 | |||
| Basic EPS | -1.27 | |||
| Diluted EPS | -1.27 | |||
| Basic Average Shares | 16,730,274 | |||
| Diluted Average Shares | 16,730,274 | |||
Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (COYA)